KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization169,238 mln
Float2.23 mln
Earnings Date08/12/2025
EPS
10,913
Exceptional
P / E
3.26
Deeply undervalued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.44
Borderline
Relative Strength
68
/ 100
Outperforming
Debt / Equity
0.92
Moderate leverage
Business Description
Founded over 80 years ago and headquartered in Seoul, Chong Kun Dang Holdings is a South Korean company that produces and sells medicine both at home and in markets around the world.
